These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29708949)

  • 21. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
    Macher-Göppinger S
    Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
    Udager AM; Mehra R
    Arch Pathol Lab Med; 2016 Oct; 140(10):1026-37. PubMed ID: 27684973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal epithelial neoplasms: diagnostic applications of gene expression profiling.
    Young AN; Master VA; Paner GP; Wang MD; Amin MB
    Adv Anat Pathol; 2008 Jan; 15(1):28-38. PubMed ID: 18156810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
    Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
    Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
    Hacking SM; Pavlick D; Wang Y; Carneiro BA; Mullally M; Lu S; Canepa M; Bratslavsky G; Jacob J; Necchi A; Spiess PE; Wang L; Yakirevich E; Ross J
    Oncologist; 2023 Jul; 28(7):e508-e519. PubMed ID: 36917021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
    Arsanious A; Bjarnason GA; Yousef GM
    Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Surg Pathol Clin; 2022 Dec; 15(4):713-728. PubMed ID: 36344185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
    Sanfrancesco JM; Cheng L
    Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma.
    DiNatale RG; Sanchez A; Hakimi AA; Reznik E
    Urol Oncol; 2020 Oct; 38(10):755-762. PubMed ID: 31155438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
    Greco FA; Hainsworth JD
    Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.
    Vieira J; Henrique R; Ribeiro FR; Barros-Silva JD; Peixoto A; Santos C; Pinheiro M; Costa VL; Soares MJ; Oliveira J; Jerónimo C; Teixeira MR
    Genes Chromosomes Cancer; 2010 Oct; 49(10):935-47. PubMed ID: 20629095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.
    El Naili R; Nicolas M; Gorena A; Policarpio-Nicolas ML
    Diagn Cytopathol; 2017 May; 45(5):456-462. PubMed ID: 28185421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma.
    Gupta S; Sukov WR; Vanderbilt CM; Shen W; Herrera-Hernandez L; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Jimenez RE; Cheville JC
    Urol Oncol; 2022 Dec; 40(12):512-524. PubMed ID: 34092479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney Tumors: New and Emerging Kidney Tumor Entities.
    Siadat F; Mansoor M; Hes O; Trpkov K
    Clin Lab Med; 2023 Jun; 43(2):275-298. PubMed ID: 37169446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.
    Kubiliute R; Jarmalaite S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.